Metastatic Pancreatic Ductal Adenocarcinoma clinical trials at UCSD
1 in progress, 0 open to new patients
Sorry, not currently recruiting here
This is a Phase 1, open label, multi center, multiple dose, dose escalation, safety, pharmacokinetic and pharmacodynamic study of palbociclib in combination with nab-P, in sequential cohorts of adult patients with mPDAC, with MTD expansion cohort(s). Approximately 30-60 patients are expected to be enrolled in the overall study.
Encinitas, California and other locations